Dr. Steven H. Lin, MD
Claim this profileM D Anderson Cancer Center
Area of expertise
Esophageal Cancer
Steven H. Lin, MD has run 3 trials for Esophageal Cancer. Some of their research focus areas include:
Lung Cancer
Steven H. Lin, MD has run 3 trials for Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
M D Anderson Cancer Center
MD Anderson In Sugar Land
Clinical Trials Steven H. Lin, MD is currently running
NBTXR3 + Chemoradiation
for Esophageal Cancer
The purpose of this Phase I study is to determine the recommended phase 2 dose (RP2D) and safety profile of NBTXR3 activated by radiation therapy with concurrent chemotherapy for the treatment of patients with esophageal adenocarcinoma. NBTXR3 is a drug that when activated by radiation therapy, may cause targeted destruction of cancer cells. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Chemotherapy drugs, such as oxaliplatin, fluorouracil, capecitabine, docetaxel, paclitaxel, and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving NBTXR3 activated by radiation therapy with concurrent chemotherapy may help control the disease.
Recruiting
3 awards
Phase 1
18F-FSPG PET/CT
for Esophageal Cancer
This study is being done to learn how 18F-FSPG PET/CT scan results may be related to the response to chemotherapy and radiation in patients with esophageal cancer.
Recruiting
1 award
N/A
5 criteria
More about Steven H. Lin, MD
Clinical Trial Related
13 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Steven H. Lin, MD has experience with
- Carboplatin
- Paclitaxel
- Radiation Therapy
- Durvalumab
- ArabinoFuranosylGuanine [18F]F-AraG
- MPDL3280A
Breakdown of trials Steven H. Lin, MD has run
Esophageal Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Esophageal Adenocarcinoma
Esophageal cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Steven H. Lin, MD specialize in?
Steven H. Lin, MD focuses on Esophageal Cancer and Lung Cancer. In particular, much of their work with Esophageal Cancer has involved Stage III patients, or patients who are Stage II.
Is Steven H. Lin, MD currently recruiting for clinical trials?
Yes, Steven H. Lin, MD is currently recruiting for 4 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Steven H. Lin, MD has studied deeply?
Yes, Steven H. Lin, MD has studied treatments such as Carboplatin, Paclitaxel, Radiation Therapy.
What is the best way to schedule an appointment with Steven H. Lin, MD?
Apply for one of the trials that Steven H. Lin, MD is conducting.
What is the office address of Steven H. Lin, MD?
The office of Steven H. Lin, MD is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.